Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14200 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Sandra Askman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Lenalidomide, Neutrophils, Multiple Myeloma, Phagocytosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Knut och Alice Wallenbergs Stiftelse, Swedish Cancer Foundation, Region Skåne.
Abstract (Originalsprache)
Objectives
Bacterial infections are common and a major cause of morbidity and mortality in multiple myeloma (MM). We have investigated the function of polymorphonuclear leukocyte (PMN), the immune system's first line of defense against bacteria, in peripheral blood (PB) and bone marrow (BM) samples from patients with newly diagnosed MM (NDMM), smoldering MM (SMM), monoclonal gammopathy of undetermined significance (MGUS) and healthy controls.
Methods
Phagocytosis and oxidative burst in PMN cells from patients and healthy donors were investigated using PhagoTest and PhagoBurst assay.
Results
PMN from NDMM, SMM, and MGUS patients had reduced phagocytosis and oxidative burst ability compared with healthy controls. The dysfunction was most prominent in BM samples from MM, SMM, and MGUS patients. Importantly the reduced phagocytosis in MM patients was restored in patients on lenalidomide therapy. Consistently the ability of Escherichia coli stimulated oxidative burst in BM was reduced for the MM, SMM, and MGUS cohort in contrast to the healthy controls and the patients on lenalidomide treatment.
Conclusion
Our results show that MM patients have neutrophil dysfunction that could contribute to susceptibility for bacterial infections and that lenalidomide therapy was associated with restored PMN function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund, Sweden.
- Department of Hematology, BMC B13, Lund University, Lund, Sweden.
- Department of Clinical Sciences, Nephrology, Skane University Hospital, Lund University, Lund, Sweden.
- Clinical Genetics and Pathology, Skåne University Hospital, Lund, Sweden.
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Sandra Askman, Åsa Pettersson, Thomas Hellmark, Åsa Johansson, Stina Wichert, Markus Hansson
Förderung
- Knut och Alice Wallenbergs Stiftelse
- Swedish Cancer Foundation
- Region Skåne
Zitieren
APA
Askman, S., Westerlund, J., Pettersson, Å., Hellmark, T., Johansson, Å., Wichert, S., & Hansson, M. (2024). Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy. European Journal of Haematology. https://doi.org/10.1111/ejh.14200
Vancouver
Askman S, Westerlund J, Pettersson Å, Hellmark T, Johansson Å, Wichert S, et al. Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy. European Journal of Haematology. 2024. doi:10.1111/ejh.14200
BibTeX
@article{Askman2024,
author = {Askman, Sandra and Westerlund, Julia and Pettersson, Åsa and Hellmark, Thomas and Johansson, Åsa and Wichert, Stina and Hansson, Markus},
title = {Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14200}
}
EUVIMED